Products

Engage Bio is a biotechnology company pioneering the development of Tethosomes, a novel class of non-viral DNA medicines designed to overcome the traditional challenges of potency and toxicity in genetic therapies. By utilizing lipid nanoparticle (LNP) technology, Engage Bio delivers therapeutic DNA alongside mRNA encoding their proprietary Tethosome protein. This protein facilitates the localization of DNA to the nucleus, enhancing gene expression by over 100-fold. Importantly, the Tethosome pl

Abalone Bio is a biotechnology company dedicated to developing innovative antibody-based therapeutics targeting G protein-coupled receptors (GPCRs). Their proprietary platform enables the discovery and optimization of antibodies that modulate GPCR activity, addressing a wide range of diseases with unmet medical needs. By focusing on GPCRs, which play a crucial role in various physiological processes, Abalone Bio aims to create more effective and selective treatments for conditions such as cancer

Nomic Bio is a biotechnology company dedicated to making proteomics accessible, scalable, and routine. Utilizing its proprietary nELISA® technology, Nomic delivers large-scale, quantitative, and cost-effective protein data to accelerate discovery, development, and translation. Their end-to-end service combines flexible content, expert support, and analysis-ready outputs, enabling seamless integration of proteomics across all stages of drug and biomarker development. Key Features and Functionali

Ochre Bio is a biotechnology company dedicated to developing RNA-based therapies for chronic liver diseases, aiming to eliminate the necessity for liver transplants. By integrating advanced genomics, artificial intelligence, and experimental biology, Ochre Bio focuses on creating treatments that regenerate diseased livers and enhance donor liver viability. Key Features and Functionality: - Human Discovery Platform: Ochre Bio has invested over $20 million to build comprehensive human liver data

Asher Biotherapeutics is a biotechnology company pioneering a novel approach to immunotherapy through its proprietary cis-targeting platform. This innovative technology enables the selective activation of specific immune cell types, thereby enhancing therapeutic efficacy while minimizing off-target effects. By precisely engaging immune cells that drive desired responses, Asher Bio aims to overcome the limitations of conventional immunotherapies that often act indiscriminately on multiple cell ty

Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.

Diffuse Bio is a pioneering company specializing in the application of generative artificial intelligence to protein design. Their platform enables the rapid engineering of novel and functional proteins with unprecedented control and accuracy, transforming the traditional, time-consuming laboratory processes into efficient computational tasks. By leveraging AI and extensive biological data, Diffuse Bio accelerates the development of protein therapeutics, allowing researchers to design protein bi

Sable Bio is a biotechnology company that leverages artificial intelligence to revolutionize drug safety assessments. Their AI-powered platform, Sable Target Intelligence, integrates comprehensive safety data across clinical, genetic, experimental, and literature sources, enabling researchers to systematically evaluate and prioritize toxicology risks. By providing unified and up-to-date safety information, Sable Bio empowers scientists to make faster, more informed decisions, ultimately accelera

Converge Bio is a pioneering company that integrates Generative AI with biological data to revolutionize drug discovery and development. By leveraging Large Language Models (LLMs) trained on the unique syntax of biological systems, Converge enables biotech and pharmaceutical companies to predict biological outcomes, gain deeper insights, and generate novel molecular candidates. This approach enhances the understanding of complex molecular interactions, signaling pathways, and disease mechanisms,

Differential Bio is pioneering the integration of biology and computation to revolutionize biomanufacturing. Their platform serves as the computational backbone for applying BioAI to regenerative manufacturing, enabling a shift from traditional trial-and-error methods to predictive, digital-first experimentation. This approach accelerates the development of biomanufactured products, making the process faster, more cost-effective, and smarter.

Nabla Bio is a biotechnology company specializing in the de novo design of antibody therapeutics through the integration of artificial intelligence (AI) and experimental technologies. Founded by experts from George Church's Lab at Harvard, Nabla Bio combines generative AI models with large-scale multiplex experiments to engineer protein-based therapies, particularly targeting applications where traditional discovery methods have been less effective.

Talus Bio is a biotechnology company specializing in the discovery and development of therapeutics targeting previously undruggable transcription factors—proteins that regulate gene expression and are implicated in various diseases, including cancer, diabetes, and neurological conditions. Founded in 2020 and based in Seattle, Talus Bio integrates advanced proteomics, synthetic chemistry, artificial intelligence, and computational biology to engineer and analyze drugs, proteins, and genomics at a

Profluent Bio's platform leverages advanced artificial intelligence to design and generate novel proteins, transcending traditional methods of random discovery. By integrating frontier foundation models with an in-house wet laboratory, Profluent enables the creation of proteins tailored for specific applications, ranging from therapeutics to industrial enzymes. This AI-driven approach allows for the design of proteins inspired by natural scaffolds or entirely reimagined structures, offering solu

Formation Bio is a pharmaceutical company dedicated to revolutionizing drug development by integrating advanced technology and artificial intelligence (AI) across the entire development lifecycle. By leveraging a modern data stack, large language models (LLMs), and AI agents, Formation Bio aims to accelerate the delivery of new treatments to patients more efficiently.

Synthetic biotechnology and ML to accelerate drug development, allowing researchers to discover, optimize, and characterize drugs more efficiently.

It's a link in bio platform for creators to showcase their online presence via single link! Build beautiful and interactive link in bio pages with easy to use bio page builder.

Snthesis software is purposely built to automatically ingest, consolidate, and harmonize structured and unstructured data from disparate systems and sources, and in nearly any format. Integrate spreadsheets, along with ELN, LIMS and CRO data into one harmonized dataset with a unified view, all on your infrastructure. Leverage data within the Snthesis UI or export to downstream analysis tools (or a Data Lake). Search Everything!

Launching a new category of pre-clinical research with AI-driven insights from functional human organs in 'Human Data Trials'.

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

Dash Bio is a modern automated platform.